−0.39USD
−95.90 MUSD
6.23 MUSD
122.70 M
About Precigen, Inc.
Sector
Industry
CEO
Helen Sabzevari
Website
Headquarters
Germantown
Employees (FY)
202
Founded
1998
ISIN
US74017N1054
FIGI
BBG000QL8VH9
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
PGENBiotech sector needs some love, this stock right here has had significant insider buying within the last 3 months. Although the right idea is to wait for profitability, regular investors should keep an eye on this t enter a long position if the price were to drop to $ 1.33 USD again in value. Anyt
Precigen Announces Clearance of IND to Initiate Phase 1/1b StudyPGEN: Precigen, Inc.
2021-10-26 08:05:00
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors
PGEN earnings beat, 9 breakout of daily flagPGEN is a pretty beaten up stock, had a recent surprise ER and looking over the past it performs decent in the days following a beat. As well a long daily flag has been created and was broken on a Friday of last week. The continuation did not hold on Friday but it was Friday and they suck for breako
paytience will payout here small downtrend channel here, should head back to 11 once it breaks though. the question is will it break and when? I wouldn't get in unless we see confirmation, for now its possible we see a dip to 7 before running back to 11+ be paytient! and goodluck :)
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PGEN is 1.31 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Precigen, Inc. stocks are traded under the ticker PGEN.
Precigen, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
PGEN stock is 5.86% volatile and has beta coefficient of 2.58. Check out the list of the most volatile stocks — is Precigen, Inc. there?
One year price forecast for Precigen, Inc. has a max estimate of 14.00 USD and a min estimate of 6.00 USD.
PGEN earnings for the last quarter are −0.08 USD whereas the estimation was −0.08 USD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.08 USD. See more details about Precigen, Inc. earnings.
Precigen, Inc. revenue for the last quarter amounts to 1.38 M USD despite the estimated figure of 1.60 M USD. In the next quarter revenue is expected to reach 2.13 M USD.
Yes, you can track Precigen, Inc. financials in yearly and quarterly reports right on TradingView.
PGEN stock has fallen by 9.03% compared to the previous week, the month change is a 5.76% fall, over the last year Precigen, Inc. has showed a 16.96% increase.
PGEN net income for the last quarter is −33.06 M USD, while the quarter before that showed −19.80 M USD of net income which accounts for −66.99% change. Track more Precigen, Inc. financial stats to get the full picture.
Today Precigen, Inc. has the market capitalization of 326.08 M, it has increased by 1.44% over the last week.
No, PGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Precigen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 202.00 employees. See our rating of the largest employees — is Precigen, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Precigen, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Precigen, Inc. stock shows the strong sell signal. See more of Precigen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Precigen, Inc. future price: according to them, PGEN price has a max estimate of 14.00 USD and a min estimate of 6.00 USD. Read a more detailed Precigen, Inc. forecast: see what analysts think of Precigen, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Precigen, Inc. EBITDA is −82.26 M USD, and current EBITDA margin is −1.32 K%. See more stats in Precigen, Inc. financial statements.